際際滷

際際滷Share a Scribd company logo
THE MALE BREAST:
Breast tumor and
Gynecomastia
Introduction to male breast tumor..
Male breast carcinoma is a
rare disease
 < 1% of all malignancies in men
 1% of all breast cancers
Introduction to male breast
tumor:
 BREAST TUMOR IN MALES
 Testicular tumor such as leydig cell tumors or sertoli
cell tumor such as (peutz Jeghers syndrome) or human
chorionic gonadotropin (Hcg) secreting
choriocarcinoma may result in gynecomastia. Other
tumors such adrenocortical tumors,pituitary gland
tumors (such as, prolactinoma) or broncchogenic
carcinoma, can produce hormones that alter male
female hormone balance and cause gynecomastia.
Introduction to male breast tumor:
 Clinically suspicious lesions
 Imaging evaluation
 Mammography
 In patients with questionable findings at
mammography and for lesions that are difficult to
image with mammography
 The relationship of the mass to the nipple should be
carefully assessed
 an eccentric location is highly suspicious for
cancer.
 The breast tissues of both sexes are
identical at birth
 Estrogen stimulates breast tissue
 Androgen antagonizes these effects
 At puberty in boys - increase in
estrogen,testosterone
Transient proliferation of the ducts and
stroma
Followed by involution and ultimate atrophy of
the ducts.
Breast Development
Normal Male Breast
 Characterized:
 Subcutaneous fat
 Remnant of
subareolar ductal
tissue
 Lobular development -
which requires both
estrogen and
progesterone, is usually
not observed in men
Normal Male Breast
Anatomy of the normal male breast- consists of the skin
and subcutaneous fat. The pectoralis fascia (PF),
pectoralis muscle (PM), ribs,and intercostal muscles
(ICM)
Introduction
 The two most important disease of the male breast
Gynecomastia
Breast cancer/tumor
 The majority of lesions in male breasts are benign
 Other disease arise from the skin&subcutan.
 Fat necrosis
 Lipoma
 Epidermal inclusion cyst
Imaging of the Male Breast
Mammography - to diagnose gynecomastia and breast
carcinoma
Diagnostic mammography
biopsy
 Standard mammographic views -
Magnification and spot compression views
 suspicious findings on mammography
 effective for evaluating male patient as it is for
female
Male Breast Tumor
 Male breast tumor - uncommon
 less than 1% of all malignancies
in men
 only 1% of all breast cancers
 The mean age of diagnosis is 67
years
 Less than 6% of cases occur in males
under the age of 40 years.
Male Breast Tumor..
 Clinical manifestation (S/S) 
 hard , fixed , painless mass
 Bloody nipple discharge common
 Secondary signs occur earlier in male patients
because of smaller breast size.
 nipple retraction,
 skin ulceration,
 thickening,
 increased breast trabeculation
Palpable axillary lymph nodes are present in about
50% of cases
Male Breast tumor
 Histologic subtype :
 Invasive ductul carcinoma- most common 
85%
 Male breast contains only ducts
 Invasive lobular  rare 
 No lobules formation in male breast
Male Breast Tumor :
 Treatment
 Same as for women
Surgery
Axillary node dissection
Chemotherapy
Radiation therapy
Surgery of Left 京姻艶温壊岳
Male Breast Cancer- Mammographic
Appearance
 Location - Subareolar position , eccentric to the nipple
 Margins  well-defined, ill-defined, spiculated
 Shape  round, oval, irregular , lobulated
 Calcification  few , coarser
 Secondary signs  skin thickening, nipple retraction , axillary
lymphadenopathy
Invasive Duct Carcinoma
GYNECOMASTIA IN MALES:
Defination Of
Gynecomastia
 Gynecomastia is enlargement of
the gland tissue of the male breast
. During infancy , puberty
,and in middle aged to older men
gynecomastia can be common
Gynecomastia
 Gynecomastia is the most common benign condition of the male
breast
 It is enlargement of the male breast due to benign
ductal and stromal proliferation.
Causes breast enlargement
/subareolar mass with/without
associated breast pain
 It can be unilateral, bilateral symmetric, or bilateral
asymmetric.
Gynecomastia
 The hallmark of gynecomastia is its central
symmetric location under the nipple
 Reversible in early stages  if the cause is
corrected
 Reversible phase progress to late periductal
edema with irreversible stromal fibrosis
Causes of Gynecomastia
 Physiologic:
 Senescence
 Puberty
 Hormonal :
 Klinefelter syndrome
 Hypogonadism
 Systemic disease:
 Cirrhosis
 Chronic renal
insufficiency
 Lavender oil & tea tree
oil when used as skin
care product
 Neoplasm:
 Adrenal carcinoma
 Pituitary adenoma
 Hepatocellular carcinoma
 Drug use:
 Cimetidine
 Marijuana & HEROIN
 Thiaside diuretics
 Omeprazole
 Tricyclic antidepresasants
 Spironolactone
 Diazepam{VALIUM}
 Anabolic steroids
 Exogenouis estrogen
Gynecomastia
 Associated with increased levels of estradiol and decreased
levels
of testosterone
 Endocrine and hormonal disorders
 Systemic disease
 Neoplasm
 Drugs :
 Spirolactone {aldactone} a diuretics that has anti
androgenic activity
 For hypertension {captopril [capoten] ,enalapril
[vasotec]
 Anti ulcerative drugs for example : Ranitidine[rantac
or zantac] ,cimetidine [tagamet] and omeprazole
[prilosec]
 Cardio problems: digitoxin
 Some antibiotics for example : isoniazid,ketoconazole
[nizoral, extina , xolegel , kuric and metronidazole [
flagyl ]
TYPES Of Gynecomastia 
 mammographic patterns -representing various degrees and
stages of ductal and stromal proliferation
 Nodular gynecomastia
 Dendritic gynecomastia
 Diffuse glandular gynecomastia
Gynecomastia
 Nodular G.- most common  77%
 Pathology  florid g.  early phase
 patients with gynecomastia < 1year
 The majority of patients will present with
 nipple tenderness , palpable lump
 Mammography-nodular subareolar density
 The typical mammographic confirms the diagnosis and
requires no further imaging work-up.
Mammography - Nodular G.
Nodular subareolar density
Nodular Gynecomastia
 a subareolar fan- or disk-shaped hypoechoic nodule
surrounded by normal fatty tissue
 The zone of transition may be poorly defined, with
lobular margin
 Hypervascularity can be seen secondary to stromal
proliferation
 In cases of equivocal clinical and mammographic
findings
 follow-up evaluation
Chronic Dendritic Gynecomastia
 Chronic dendritic gynecomastia (quiescent
phase) -20%
 Patients with gynecomastia > 1 year.
 Pathology  fibrous g.- long standing gynecomastia
 Fibrosis becomes the dominant process and is irreversible.
 Mammography - dendritic subareolar
density with posterior linear projections
radiating into the surrounding tissue
toward the uoq
Chronic Dendritic
Gynecomastia
 a subareolar hypoechoicstar-shaped,
fingerlike projections or spider legs
 benignity - directly from the undersurface
of the nipple without causing any overlying
skin thickening or nipple retraction.
Chronic Dendritic Gynecomastia
U.S image subareolar hypoechoic nodule with star-shaped
projections into the surrounding echogenic fibrous tissue
Chronic Dendritic
Gynecomastia
 The clinical history, particularly the duration of
symptoms, can also be helpful in making this
diagnosis.
 patients may have an acute episode of gynecomastia in
addition to chronic dendritic gynecomastia.Both phases
can be seen at imaging simultaneously.
Diffuse Glandular Gynecomastia
Diffuse glandular  3%
 Patients receiving exogenous estrogen
 Mammography- enlargement of the breast , similar to
heterogeneously dense female breast.
 Irreversible stromal fibrosis and ductal epithelial atrophy develop, the
breast enlargement may decrease but not completely resolve.
 both nodular and dendritic features are seen surrounded by
diffuse hyperechoic fibrous breast tissue.
Diffuse Glandular Gynecomastia
Enlargement of the breast and
diffuse density with both dendritic
and nodular features
Pseudogynecomastia
 Pseudogynecomastia  a fatty proliferation of the
breasts , without proliferation of glandular tissue.
 Difficult to distinguish from normal male breast on
mammography
 Diagnosis requires clinical correlation with breast
enlargement
Less Common Benign
Conditions
 Lipoma - second most common benign lesion in the
male breast
 Mammography typically shows a subtle
encapsulated fatty mass in the palpated area
 demonstrates one or multiple parallel, homogeneous,
and mildly hyperechoic masses under the skin
 capsule is sometimes seen
Lipoma
Parallel, homogeneous, mildlyhyperechoic
mass with a capsule (arrow) under the skin.
Subtle encapsulated fatty mass
(arrows) in the palpated region.
Epidermal Inclusion Cyst
 Epidermal inclusion cyst is the third most common benign
lesion in the male breast
 Arise from obstructed or occluded hair follicles, at the sites of
previous skin trauma such as a surgical wound or insect bites
 Composed of laminated keratin surrounded by stratified
squamous epithelium
Epidermal Inclusion Cyst
Hypoechoic lesion, which is contiguous to
the epidermis (arrows) (the claw sign) with
increased through transmission
well defined, dense, oval
mass contiguous to the skin in
the palpated region.
Benign Conditions
Associated with Gynecomastia
 Pseudoangiomatous stromal hyperplasia (PASH)-
benign stromal tumor formed by myofibroblasts
and with glandular hyperplasia
 Often incidentally seen in gynecomastia
 Mammography- non calcified breast mass,
circumscribed or partially circumscribed
solid circumscribed hyper echoic masses
 Recurrence is common after resection
PASH
Dense circumscribed mass
Solid hyperechoic mass with
posterior acoustic shadowing
Intraductal Papilloma
 Intraductal papilloma - benign proliferation of
intraductal mammary epithelium.
 Mammography - discrete dense mass against a
background of subareolar changes consistent
with gynecomastia
 multiple encentric, subareolar, elongated
and welldefined hypoechoic masses, which
have irregular shapes and are possibly
confined to the lumina of markedly enlarged
central ducts
Intraductal papilloma
multiple eccentric, subareolar, elongated,well-defined,
hypoechoic masses ;US image shows cystic areas, which may
represent associated ductal ectasia.
discrete dense mass against a background of
subareolar density, which consistent with
gynecomastia
DIAGNOSTIC
EVALUATION
 COMPLETE ASSESSMENT OF MALE
PATIENTS BREAST,
 COMPLETE BLOOD COUNT(CBC)
 MAMOGRAPHY,
 ULTRASOUND,
 FNAC
[FINE NEEDLE ASPIRATION
CYTOLOGY],
 LIVER FUNCTION TEST AND
 HORMONAL ASSESSMENT.
Conclusions
 The majority (99%) of male breast lesions are benign
 Mammography- for clinically suspicious lesions
 accurate for diagnosing gynecomastia
 useful for further characterization
 The relationship of the mass to the nipple should be carefully
assessed
 Encentric location is highly suspicious for cancer
the axillary region is helpful for staging In men
- cystic lesions commonly malignant
Cysts and complex masses should be worked up as potentially
malignant lesions
Suspicious lesion - biopsy - guidance is usually preferred
RISK FACTORS & COMPLICATIONS..
 advanced age
 prior irradiction of the chest
 exogenous estrogen for prostate
cancer treatment
 gender-reassignment procedures
 liver disease and other diseases
associated with hyperestrogenism,
androgen deficiency due to testicular
dysfunction
 genetic and chromosomal conditions
- Klinefelter syndrome.
MANAGEMENT
 MEDICAL MANAGEMENT :
 RADIOTHERAPHY,
 CHEMOTHERAPHY.
 SURGICAL MANAGEMENT:
 SURGERY OF THE CANCEROUS PART

More Related Content

Mammography

  • 1. THE MALE BREAST: Breast tumor and Gynecomastia
  • 2. Introduction to male breast tumor.. Male breast carcinoma is a rare disease < 1% of all malignancies in men 1% of all breast cancers
  • 3. Introduction to male breast tumor: BREAST TUMOR IN MALES Testicular tumor such as leydig cell tumors or sertoli cell tumor such as (peutz Jeghers syndrome) or human chorionic gonadotropin (Hcg) secreting choriocarcinoma may result in gynecomastia. Other tumors such adrenocortical tumors,pituitary gland tumors (such as, prolactinoma) or broncchogenic carcinoma, can produce hormones that alter male female hormone balance and cause gynecomastia.
  • 4. Introduction to male breast tumor: Clinically suspicious lesions Imaging evaluation Mammography In patients with questionable findings at mammography and for lesions that are difficult to image with mammography The relationship of the mass to the nipple should be carefully assessed an eccentric location is highly suspicious for cancer.
  • 5. The breast tissues of both sexes are identical at birth Estrogen stimulates breast tissue Androgen antagonizes these effects At puberty in boys - increase in estrogen,testosterone Transient proliferation of the ducts and stroma Followed by involution and ultimate atrophy of the ducts. Breast Development
  • 6. Normal Male Breast Characterized: Subcutaneous fat Remnant of subareolar ductal tissue Lobular development - which requires both estrogen and progesterone, is usually not observed in men
  • 7. Normal Male Breast Anatomy of the normal male breast- consists of the skin and subcutaneous fat. The pectoralis fascia (PF), pectoralis muscle (PM), ribs,and intercostal muscles (ICM)
  • 8. Introduction The two most important disease of the male breast Gynecomastia Breast cancer/tumor The majority of lesions in male breasts are benign Other disease arise from the skin&subcutan. Fat necrosis Lipoma Epidermal inclusion cyst
  • 9. Imaging of the Male Breast Mammography - to diagnose gynecomastia and breast carcinoma Diagnostic mammography biopsy Standard mammographic views - Magnification and spot compression views suspicious findings on mammography effective for evaluating male patient as it is for female
  • 10. Male Breast Tumor Male breast tumor - uncommon less than 1% of all malignancies in men only 1% of all breast cancers The mean age of diagnosis is 67 years Less than 6% of cases occur in males under the age of 40 years.
  • 11. Male Breast Tumor.. Clinical manifestation (S/S) hard , fixed , painless mass Bloody nipple discharge common Secondary signs occur earlier in male patients because of smaller breast size. nipple retraction, skin ulceration, thickening, increased breast trabeculation Palpable axillary lymph nodes are present in about 50% of cases
  • 12. Male Breast tumor Histologic subtype : Invasive ductul carcinoma- most common 85% Male breast contains only ducts Invasive lobular rare No lobules formation in male breast
  • 13. Male Breast Tumor : Treatment Same as for women Surgery Axillary node dissection Chemotherapy Radiation therapy
  • 14. Surgery of Left 京姻艶温壊岳
  • 15. Male Breast Cancer- Mammographic Appearance Location - Subareolar position , eccentric to the nipple Margins well-defined, ill-defined, spiculated Shape round, oval, irregular , lobulated Calcification few , coarser Secondary signs skin thickening, nipple retraction , axillary lymphadenopathy
  • 18. Defination Of Gynecomastia Gynecomastia is enlargement of the gland tissue of the male breast . During infancy , puberty ,and in middle aged to older men gynecomastia can be common
  • 19. Gynecomastia Gynecomastia is the most common benign condition of the male breast It is enlargement of the male breast due to benign ductal and stromal proliferation. Causes breast enlargement /subareolar mass with/without associated breast pain It can be unilateral, bilateral symmetric, or bilateral asymmetric.
  • 20. Gynecomastia The hallmark of gynecomastia is its central symmetric location under the nipple Reversible in early stages if the cause is corrected Reversible phase progress to late periductal edema with irreversible stromal fibrosis
  • 21. Causes of Gynecomastia Physiologic: Senescence Puberty Hormonal : Klinefelter syndrome Hypogonadism Systemic disease: Cirrhosis Chronic renal insufficiency Lavender oil & tea tree oil when used as skin care product Neoplasm: Adrenal carcinoma Pituitary adenoma Hepatocellular carcinoma Drug use: Cimetidine Marijuana & HEROIN Thiaside diuretics Omeprazole Tricyclic antidepresasants Spironolactone Diazepam{VALIUM} Anabolic steroids Exogenouis estrogen
  • 22. Gynecomastia Associated with increased levels of estradiol and decreased levels of testosterone Endocrine and hormonal disorders Systemic disease Neoplasm Drugs : Spirolactone {aldactone} a diuretics that has anti androgenic activity For hypertension {captopril [capoten] ,enalapril [vasotec] Anti ulcerative drugs for example : Ranitidine[rantac or zantac] ,cimetidine [tagamet] and omeprazole [prilosec] Cardio problems: digitoxin Some antibiotics for example : isoniazid,ketoconazole [nizoral, extina , xolegel , kuric and metronidazole [ flagyl ]
  • 23. TYPES Of Gynecomastia mammographic patterns -representing various degrees and stages of ductal and stromal proliferation Nodular gynecomastia Dendritic gynecomastia Diffuse glandular gynecomastia
  • 24. Gynecomastia Nodular G.- most common 77% Pathology florid g. early phase patients with gynecomastia < 1year The majority of patients will present with nipple tenderness , palpable lump Mammography-nodular subareolar density The typical mammographic confirms the diagnosis and requires no further imaging work-up.
  • 25. Mammography - Nodular G. Nodular subareolar density
  • 26. Nodular Gynecomastia a subareolar fan- or disk-shaped hypoechoic nodule surrounded by normal fatty tissue The zone of transition may be poorly defined, with lobular margin Hypervascularity can be seen secondary to stromal proliferation In cases of equivocal clinical and mammographic findings follow-up evaluation
  • 27. Chronic Dendritic Gynecomastia Chronic dendritic gynecomastia (quiescent phase) -20% Patients with gynecomastia > 1 year. Pathology fibrous g.- long standing gynecomastia Fibrosis becomes the dominant process and is irreversible. Mammography - dendritic subareolar density with posterior linear projections radiating into the surrounding tissue toward the uoq
  • 28. Chronic Dendritic Gynecomastia a subareolar hypoechoicstar-shaped, fingerlike projections or spider legs benignity - directly from the undersurface of the nipple without causing any overlying skin thickening or nipple retraction.
  • 29. Chronic Dendritic Gynecomastia U.S image subareolar hypoechoic nodule with star-shaped projections into the surrounding echogenic fibrous tissue
  • 30. Chronic Dendritic Gynecomastia The clinical history, particularly the duration of symptoms, can also be helpful in making this diagnosis. patients may have an acute episode of gynecomastia in addition to chronic dendritic gynecomastia.Both phases can be seen at imaging simultaneously.
  • 31. Diffuse Glandular Gynecomastia Diffuse glandular 3% Patients receiving exogenous estrogen Mammography- enlargement of the breast , similar to heterogeneously dense female breast. Irreversible stromal fibrosis and ductal epithelial atrophy develop, the breast enlargement may decrease but not completely resolve. both nodular and dendritic features are seen surrounded by diffuse hyperechoic fibrous breast tissue.
  • 32. Diffuse Glandular Gynecomastia Enlargement of the breast and diffuse density with both dendritic and nodular features
  • 33. Pseudogynecomastia Pseudogynecomastia a fatty proliferation of the breasts , without proliferation of glandular tissue. Difficult to distinguish from normal male breast on mammography Diagnosis requires clinical correlation with breast enlargement
  • 34. Less Common Benign Conditions Lipoma - second most common benign lesion in the male breast Mammography typically shows a subtle encapsulated fatty mass in the palpated area demonstrates one or multiple parallel, homogeneous, and mildly hyperechoic masses under the skin capsule is sometimes seen
  • 35. Lipoma Parallel, homogeneous, mildlyhyperechoic mass with a capsule (arrow) under the skin. Subtle encapsulated fatty mass (arrows) in the palpated region.
  • 36. Epidermal Inclusion Cyst Epidermal inclusion cyst is the third most common benign lesion in the male breast Arise from obstructed or occluded hair follicles, at the sites of previous skin trauma such as a surgical wound or insect bites Composed of laminated keratin surrounded by stratified squamous epithelium
  • 37. Epidermal Inclusion Cyst Hypoechoic lesion, which is contiguous to the epidermis (arrows) (the claw sign) with increased through transmission well defined, dense, oval mass contiguous to the skin in the palpated region.
  • 38. Benign Conditions Associated with Gynecomastia Pseudoangiomatous stromal hyperplasia (PASH)- benign stromal tumor formed by myofibroblasts and with glandular hyperplasia Often incidentally seen in gynecomastia Mammography- non calcified breast mass, circumscribed or partially circumscribed solid circumscribed hyper echoic masses Recurrence is common after resection
  • 39. PASH Dense circumscribed mass Solid hyperechoic mass with posterior acoustic shadowing
  • 40. Intraductal Papilloma Intraductal papilloma - benign proliferation of intraductal mammary epithelium. Mammography - discrete dense mass against a background of subareolar changes consistent with gynecomastia multiple encentric, subareolar, elongated and welldefined hypoechoic masses, which have irregular shapes and are possibly confined to the lumina of markedly enlarged central ducts
  • 41. Intraductal papilloma multiple eccentric, subareolar, elongated,well-defined, hypoechoic masses ;US image shows cystic areas, which may represent associated ductal ectasia. discrete dense mass against a background of subareolar density, which consistent with gynecomastia
  • 42. DIAGNOSTIC EVALUATION COMPLETE ASSESSMENT OF MALE PATIENTS BREAST, COMPLETE BLOOD COUNT(CBC) MAMOGRAPHY, ULTRASOUND, FNAC [FINE NEEDLE ASPIRATION CYTOLOGY], LIVER FUNCTION TEST AND HORMONAL ASSESSMENT.
  • 43. Conclusions The majority (99%) of male breast lesions are benign Mammography- for clinically suspicious lesions accurate for diagnosing gynecomastia useful for further characterization The relationship of the mass to the nipple should be carefully assessed Encentric location is highly suspicious for cancer the axillary region is helpful for staging In men - cystic lesions commonly malignant Cysts and complex masses should be worked up as potentially malignant lesions Suspicious lesion - biopsy - guidance is usually preferred
  • 44. RISK FACTORS & COMPLICATIONS.. advanced age prior irradiction of the chest exogenous estrogen for prostate cancer treatment gender-reassignment procedures liver disease and other diseases associated with hyperestrogenism, androgen deficiency due to testicular dysfunction genetic and chromosomal conditions - Klinefelter syndrome.
  • 45. MANAGEMENT MEDICAL MANAGEMENT : RADIOTHERAPHY, CHEMOTHERAPHY. SURGICAL MANAGEMENT: SURGERY OF THE CANCEROUS PART